Profits

Hospice of Michigan President and CEO Available for Comment on New England Journal of Medicine Article on Profits in Hospice Industry and Proposed Changes From MedPAC

DETROIT, June 25 /PRNewswire-USNewswire/ -- Hospice of Michigan, the state's largest hospice and one of the largest non-profit hospices in the nation, will have spokespersons available to comment on the New England Journal of Medicine's article on profits in the hospice industry published ...

Consumer Group Wants Public to Share Profits From Federally Funded Stem Cell and Medical Research

Lauds Lifting of Ban and Calls on President Obama to Follow Policies Established by California Stem Cell Agency SANTA MONICA, Calif., March 9 /PRNewswire-USNewswire/ -- Consumer Watchdog today praised President Obama for lifting Bush era restrictions on federal funding of stem cell research a...

Health Care Transparency Report Ranks Hospitals and Nursing Facilities on Efficiency and Productivity - Charity Care and Profits Increase

RICHMOND, Va., Nov. 20 /PRNewswire-USNewswire/ -- Virginia Health Information's (VHI) 2008 Industry Report identifies the most efficient and productive hospitals, nursing facilities and other providers. VHI's 2008 Industry Report has key information for businesses and purchasers on their ...

Chili's Grill & Bar(R) to Donate 100 Percent of All Profits on Monday, Sept. 29 to St. Jude Children's Research Hospital as Part of Annual Create-A-Pepper to Fight Childhood Cancer Campaign

- Chili's Aims to Reach $25 Million Milestone in 10-Year, $50 Million Commitment - MEMPHIS, Tenn., Sept. 24 /PRNewswire/ -- Chili's Grill & Bar announced today it will donate 100 percent of all profits on Monday, Sept. 29 to St. Jude Children's Research Hospital(R...

China's Leading Healthcare Market Player Records 200% Increase in Profits and Earnings

HONG KONG, June 25 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech Company Limited ("Golden Meditech" or the "Group"; Stock Code: 8180.HK) today is pleased to announce its annual results for the financial year ended 31 March 2008. Driven by remarkable organic growth of core businesses and exc...

Cord Blood America Reports First Quarter Financial Results; Gross Profits Increase

LOS ANGELES, May 21 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally...

Soy Foods Beat Out Fresh Fish and Meat for 'Best New Products Tried By Consumers' While Demand and Profits Continue to Grow

NEW YORK, April 18 /PRNewswire/ -- Soy foods have staying power according to a new report from Packaged Facts, Soy Foods and Beverages in the U.S. The soy food and beverage market topped $2 billion in 2007, up 7% from 2006, due largely to snack bar and soymilk products. Sales of soy foods and ...

The Female Health Company Reports 37% Revenue Growth and Record Profits for First Quarter of FY2008

First Quarter Highlights: - 37% Revenue Increase - 85% Gross Profit Increase - $1,040,892 "Bottom line" improvement over Prior Year CHICAGO, Feb. 13 /PRNewswire-FirstCall/ -- The Female Health Company (Amex: FHC ), wh...

ReBuilder Medical Technologies, Inc. Reports Doubled Profits for October

CHARLES TOWN, W.Va., Dec. 3 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA announces record profits for October 2007. (Logo: http://www....

Dragon Achieved Solid Increase in Sales and Profits from Continuing Operations for Q3

VANCOUVER, Nov. 14 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. (TSX: DDD; OTC BB: DRUG; BBSE: DRP) today announced its financial results for the three and nine months ended September 30, 2007, showing strong growth in sales and profits for its core antibiotic business. Meanwhile, the C...

Profits in Medical Technology

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

...l as original works of art from some of these artists. Fifty percent of the profits all Gap (PRODUCT)RED Artist Edition T-Shirts benefit the Global Fund to hel...RED mark contribute a significant percentage of the sales or portion of the profits from that product to the Global Fund to finance AIDS programs in Africa, wi...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...belimumab Phase 3 trials, with assistance from GSK. The companies will share equally in Phase 3/4 development costs, sales and marketing expenses, and profits of any product commercialized under the current agreement. About Systemic Lupus Erythematosus Systemic lupus erythematosus (SLE)...

Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion

... and other eye diseases and disorders. Bayer HealthCare will market VEGF Trap-Eye outside the United States, where the companies will share equally in profits from any future sales of VEGF Trap-Eye. Regeneron maintains exclusive rights to VEGF Trap-Eye in the United States. About Regeneron Pharmaceutic...

Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C

...HGS and Novartis will co-commercialize Albuferon in the United States and will share clinical development costs, U.S. commercialization costs and U.S. profits equally. Novartis will be responsible for commercialization in the rest of the world and will pay HGS a royalty on those sales. Clinical development, ...

Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C

...HGS and Novartis will co-commercialize Albuferon in the United States and will share clinical development costs, U.S. commercialization costs and U.S. profits equally. Novartis will be responsible for commercialization in the rest of the world and will pay HGS a royalty on those sales. Clinical development, ...

Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation

...nly the non-ApoEe4 gene carriers-a prospective population of 40 to 70 percent of Alzheimer's disease patients-bapineuzumab stands to reap considerable profits in the Alzheimer's disease market." Two new Decision Resources Alzheimer's disease reports-the Pharmacor report entitled Alzheimer's Disease and Bra...

Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration

...her ocular diseases and disorders. Once approved, Bayer HealthCare will market VEGF Trap-Eye outside the U.S., where the parties will share equally in profits from any future sales of VEGF Trap-Eye. Regeneron maintains exclusive rights to VEGF Trap-Eye in the U.S. VIEW 2 primary analysis results are anticipa...

Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials

...phoStat-B Phase 3 trials, with assistance from GSK. The companies will share equally in Phase 3/4 development costs, sales and marketing expenses, and profits of any product commercialized under the agreement. About Systemic Lupus Erythematosus Systemic lupus erythematosus (SLE) is a chronic, life-threat...

Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus

...phoStat-B Phase 3 trials, with assistance from GSK. The companies will share equally in Phase 3/4 development costs, sales and marketing expenses, and profits of any product commercialized under the agreement. About Systemic Lupus Erythematosus Systemic lupus erythematosus (SLE) is a chronic, life-threaten...

Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C

...HGS and Novartis will co-commercialize Albuferon in the United States and will share clinical development costs, U.S. commercialization costs and U.S. profits equally. Novartis will be responsible for commercialization in the rest of the world and will pay HGS a royalty on those sales. Clinical development, ...

Profits in Biological News

Biomedical research profits from the exploration of the deep sea

A study published in the scientific journal PLoS ONE highlights how the exploration of the ocean depths can benefit humankind. This is the story of a voyage of discovery, starting with marine animals that glow, the identification of the molecules responsible and their application as marker in li...

Economists: Reduce fish catch now for bigger net profits later

A new and compelling argument for reducing fish harvests the profit motive could persuade world fishers to endure the short-term pain of lower catches for the long-term gain of higher returns for their labor, according to authors of a ground-breaking study on fisheries over-exploitation. They...

Waste water treatment plant mud used as 'green' fuel

... the fuel from waste water treatment plant mud. From an economic point of view, the scientists will not say that cement plants could increase their profits by using this method, but "they will not have to pay anything to exceed their agreed emissions", the researcher points out. The economic benefits of t...

No consistent advantage for planting soybean early

...ut there was a clear disadvantage for planting late, after the critical date in late May or early June. Soybean producers can maximize their yield and profits by making sure planting is completed before the critical date. ...

Traditional Dutch landscape under threat

...ow price. However, the financial resources required for such an approach are considerable. New concepts such as cross-subsidy strategies, in which the profits from new developments are invested in green areas, are suitable for less attractive landscapes with a minimal recreational function, but do not usuall...

Synthetic biology: Is ethics a showstopper?

... biology researchers unintentionally equipping terrorists with frightening new biological weapons? And will synthetic biology's expected products and profits be stymied by policymakers and the public who object to researchers' soon-to-be-realized attempts to build life from scratch in a lab? Arthur Capla...

Book's plea: Save the bonobos

...ts, and created Blue Bark Press to get the work in print. The book sells for $19.95 and can be purchased on this Web site: www.bonobokids.org . All profits from I'm Lucy go to the Bonobo Conservation Initiative (BCI) and the Roots & Shoots program, non-profit organizations. The BCI seeks to preserve the b...

Some biofuels might do more harm than good to the environment, study finds

...he rapid rise of both food and fuel prices, she said. The issue is especially touchy for farmers who might for the first time be realizing significant profits on their crops, but it also is a serious concern for motorists. "I've heard about people getting their gas tanks siphoned, and I hadn't heard of t...

Adding up business and energy

... Could a business practice usually reserved for boosting profits be used to help turn companies green by reducing their energy use? Writing in the International Journal of Six Sigma and Competitive Advantage (IJSSCA...

Aerodynamic trailer cuts fuel and emissions by up to 15 percent

...resistance of up to 30%, which translates into a reduction in fuel consumption and emissions of as much as 15%. Moreover, it contributes to increasing profits in the highly competitive world of road transport. ...

Profits in Biological Technology

Recovering Energy and Profits From Biomass and Waste

2nd Annual EBW Expo & Conference Held in Pittsburgh - Over 1,000 Expected Attendees to Discuss New Technologies, New Business PITTSBURGH, Pennsylvania, September 24 /PRNewswire/ -- North America's premier showcase and educational forum for the growing business of using waste materials ...

Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript

BANGKOK, Thailand, Sept. 8 /PRNewswire/ -- Don Margolis, Chairman of The Repair Stem Cell Institute LLC (RSCI; http://www.RepairStemCells.org ) based in Bangkok, Thailand told The Wall Street Transcript (TWST) in an exclusive news interview published today that future profits inside the stem ...

Early-Bird Registration Ends this Week for 10th Annual Quality Excellence Conference: How Process Improvement Leaders Produce Profits in Recessions

CHAPEL HILL, N.C., Aug. 28 /PRNewswire/ -- Be inspired by historic Philadelphia, Pa. and revel in the ambiance of a five-star hotel at a discounted group room rate while you discover best practices and network with executives from Abbott, Boeing, BP, DuPont, FedEx, Hewlett-Packard, Johnson & J...

Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007

VANCOUVER, Aug. 14 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. (TSX: DDD; OTCBB: DRUG; BBSE: DRP) today announced the financial results for the second quarter ended June 30, 2007. Highlights of the Second Quarter, 2007 - Sales increased 48% to $20.55 million from $13.89 million fo...

Excipients Help Pharma Extend Product Life, Profits

NEW YORK, April 2, 2008 /PRNewswire/ -- With their ability to extend product life, excipients are being turned to increasingly as part of Big Pharma's strategy during lean times, and this portends a robust market for them, according to a new report from a major life sciences market research pu...

BoneCare doubles options and profits as fiscal year closes

Middleton, Wis. BoneCare International , a Wisconsin-based pharmaceutical firm, reported turning a profit for two straight quarters, seeing a 103 percent increase in sales and raising the prediction for 2005 sales growth to 74 percent. BoneCare's fourth-quarter net income has been reported as...

GE Healthcare third-quarter profits up 17 percent

Waukesha, Wis. -- Profits for General Electric Co.'s GE Healthcare division rose 17 percent for the third quarter behind an 8 percent growth in total orders, the company reported Friday. GE Healthcare -- the London-based parent of GE Healthcare Technologies in Waukesha -- reported revenue of...

Johnson Controls sales up, profits down

Milwaukee, Wis. Johnson Controls reported net income of $165 million for the quarter ending on December 31, down slightly from the $168 million it made in the same period a year ago. That was despite earnings growth bolstered by quarterly sales of $7.5 billion, up from $6.6 billion a year ago...

Fiserv makes over $1 billion, but profits decline

Milwaukee, Wis. Fiserv, which provides software and services to the financial and health-benefits industries, said its first-quarter revenues in 2006 were up 13 percent to $1.1 billion. Net income was $116 million, down slightly from the $140 million the company made in the first quarter of 2...

Defense contract helps Plexus gain record profits

Neenah, Wis. - Thanks to a classified contract from the defense sector, Plexus Corp. , a product realization company headquartered here, reported record revenues and earnings for its third fiscal quarter ended July 1, 2006, despite the closing of its manufacturing facility in England. The com...

More>>